Selva Therapeutics
PrivateLast Round
Series A
Jul 21, 2020
Total Funding Raised
$3M
Company Overview
Selva Therapeutics operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series A round in July 2020.
Selva Therapeutics is a biotechnology company dedicated to the development of therapeutics for infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Selva Therapeutics Comparables
Compare Selva Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Via Nova Therapeutics | 78% | |
| Pardes Biosciences | 76% | |
| Enanta Pharmaceuticals | 73% |
For institutional investors. Book with your work email.
Selva Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Monthly visitors increased 138% MoM, from 261 to 621.
For institutional investors. Book with your work email.
Selva Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Selva Therapeutics's valuation, stock price, and market status.
Is Selva Therapeutics a public or private company?
Selva Therapeutics is a private company.
What is the current stock price of Selva Therapeutics?
Selva Therapeutics is a private company, so its shares have no public market price. Caplight tracks Selva Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Selva Therapeutics worth (valuation)?
Valuation information for Selva Therapeutics is not publicly available.
Can I buy Selva Therapeutics stock?
Selva Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Selva Therapeutics's last funding round?
Selva Therapeutics's most recent funding round was Series A on July 21, 2020.
Who are the main investors in Selva Therapeutics?
Investor information for Selva Therapeutics is not publicly disclosed.
Will Selva Therapeutics IPO soon?
No public IPO plans have been announced for Selva Therapeutics.
How can I track Selva Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Selva Therapeutics's shares on secondary markets.